Aygün Şahin, MSc, PhD
About Dr. Ayguen Sahin
Dr. Ayguen Sahin is a UN award-winning scientist, founder of NeuroHyperSensitivity™ (NHS), and a global leader in responsible and ethical AI and personalized cancer care. With over 25 years of experience at the intersection of science, technology, and patient advocacy, Dr. Sahin has built a reputation for breaking barriers and redefining what’s possible in health, science, and innovation.
As the CEO and Founder of the Cancer Education and Research Institute® (CERI), Dr. Sahin’s pioneering vision and leadership were recognized by the United Nations, honoring her groundbreaking work in advancing patient-centered, holistic cancer care. Her expertise spans from cutting-edge cancer research—including CAR-T cell therapy—to the creation of NHS, a concept and movement addressing the silent, often misunderstood neurological challenges faced by high-achievers and leaders.
A passionate advocate for ethical and responsible AI in health and science, Dr. Sahin advises organizations and institutions worldwide on building trust, driving innovation, and shaping the future of healthcare technology. She is an invited speaker at the United Nations, MIT, Harvard, and numerous international conferences, and is widely recognized for her bold, science-backed insights and transformative leadership.
Dr. Sahin’s work is driven by a simple belief:
Innovation lives beyond broken systems.
She empowers leaders, organizations, and changemakers to break through
the limits of the current system and create lasting, meaningful change.
Media & Recognition:
-
UN Award Winner for Outstanding Contribution to NCD Prevention
-
Invited Speaker at the United Nations, MIT, Harvard, and more.
-
Interviews and features in Boston Globe, Milliyet, HaberTürk, and more.
To advance healthcare and technology through ethical, patient-centered, and scientifically rigorous strategies. By leading groundbreaking work in cancer research, NeuroHyperSensitivity™, and Responsible AI, I strive to bridge scientific discovery with real-world impact—ensuring that innovation remains purposeful, ethical, and centered on those it serves.
My Vision
A future where healthcare is truly personalized, where scientific advancements translate seamlessly into better patient outcomes, and where AI enhances, rather than compromises, human well-being. I envision a world where ethical innovation drives progress, empowering individuals and institutions to navigate the complexities of science and technology with integrity.
My Values
- Scientific Integrity – Upholding the highest standards of research, ensuring that data and discoveries serve humanity with accuracy and transparency.
- Ethical Innovation – Prioritizing responsible, people-centered advancements in healthcare and AI.
- Patient-Centered Impact – Ensuring that science and technology serve individuals, not just institutions.
- Lifelong Advocacy – Championing the needs of patients, individuals with NeuroHyperSensitivity™, and responsible AI users through policy, research, and education.
- Interdisciplinary Excellence – Bridging fields—medicine, science, and AI—to create comprehensive, transformative solutions.